Reset

Advanced Filters
11:00am - 12:15pm EDT - March 18, 2021

Thursday


Objectives:
  • Identify clinical challenges in managing patients with a variety of cancers.
  • Develop an evidence-based approach for the management of these patients.
Thursday
11:00am - 11:45am EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Describe current surgical management strategies for testicular germ cell tumors.
  • Assess the benefits and limitations of current surgical techniques.
  • Discuss the supportive care needs that arise during surgical management of testicular germ cell tumors.
Thursday
11:00am - 11:45am EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Discuss the impact cancer and its treatment can have on a survivor’s work status, work performance, and job satisfaction.
  • Review interventions that may enhance return-to-work in cancer survivors.
  • Explain how physical activity and other healthy lifestyle habits may help survivors return to work.
11:00am - 12:30pm EDT - March 19, 2021

Friday


Objectives:
  • Identify clinical challenges in managing patients with a variety of cancers.
  • Develop an evidence-based approach for the management of these patients.
Friday


Objectives:
  • Recognize the barriers to fertility preservation in AYAs with cancer, including lack of adequate knowledge among providers.
  • Assess the risks of gonadotoxicity/gonadal insufficiency associated with various anti-neoplastic regimens, as estimated by the standardized risk stratification model proposed by the Oncofertility Consortium.
  • Discuss the various fertility preservation methods and alternatives currently available for female and male AYAs.
Friday
11:00am - 11:45am EDT - March 19, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Evaluate novel and emerging treatment strategies for acute myeloid leukemia (AML) and integrate them into the management of appropriate patients.
  • Compare and contrast factors used for posttreatment risk stratification in AML.
  • Summarize supportive care considerations for novel and emerging AML therapies.
Friday


Objectives:
  • Recognize health-related quality of life issues that impact patients with head and neck cancer.
  • Identify strategies for optimal nutrition management in patients with head and neck cancer.
  • Describe the risk of dental complications following radiation therapy treatment to the head and neck and strategies to prevent and address complications, including use of advanced radiation therapy techniques.
Friday


Objectives:
  • Discuss the results of recent and emerging clinical trials of immune checkpoint inhibitors and their potential impact on treatment of urothelial bladder cancer.
  • Review recent updates to the NCCN Guidelines for Bladder Cancer and how they may be incorporated into clinical practice.
  • Describe systemic therapy options for patients with urothelial bladder cancer, along with how patient and disease characteristics can guide therapy choice.
Friday
11:45am - 12:30pm EDT - March 19, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Select optimal therapies for patients with heavily pretreated multiple myeloma (MM) based on individual patient and disease characteristics.
  • Manage toxicities of the newer agents and combination regimens in patients with MM.
  • Review current management strategies of SMM and MM and effectively convey the benefits and risks of clinical trial participation to patients.
03:30pm - 04:15pm EDT - March 19, 2021

Friday
03:30pm - 04:15pm EDT - March 19, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Recognize the various types of uterine sarcomas and mixed epithelial/mesenchymal tumors.
  • Discuss the challenges of differentiating between these types of tumors.
  • Describe how molecular profiling can be used to help diagnose uterine sarcomas and carcinosarcomas, assess prognosis, and guide treatment decisions.
Friday
03:30pm - 04:15pm EDT - March 19, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Describe the total neoadjuvant therapy approach for treating locally advanced rectal cancer and the results from clinical trials investigating this approach.
  • Discuss emerging treatment options for metastatic colorectal cancer and which patients might benefit from these new therapies based on clinical characteristics and biomarker results.
  • Apply clinical trial data into treatment strategies for locally advanced rectal cancer and metastatic colorectal cancer.
Friday


Objectives:
  • Review the treatment options for patients with relapsed or refractory CLL/SLL.
  • Discuss available evidence on sequencing therapy for patients with relapsed/refractory disease and develop an individualized treatment plan based on prior first-line therapy, disease-specific and patient-specific characteristics.
  • Describe the role of minimal residual disease (MRD) assessment and its implications on the management of patients with CLL/SLL.
Friday
03:30pm - 04:15pm EDT - March 19, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Describe when systemic therapy may be appropriate for patients with thyroid carcinoma.
  • Identify systemic therapy options for advanced thyroid carcinoma.
  • Recognize side effects that are commonly reported in patients with thyroid carcinoma who are treated with systemic therapy.
03:30pm - 05:00pm EDT - March 20, 2021

Saturday
03:30pm - 04:15pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Review the recommended actionable oncogenic biomarkers for eligible patients with metastatic non-small cell lung cancer (NSCLC).
  • Identify the recommended immune biomarkers for eligible patients with metastatic NSCLC.
  • Describe the need for biomarker testing for eligible patients with metastatic NSCLC.
Saturday
03:30pm - 04:15pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • List the patient and case-specific factors that should inform first-line treatment of melanoma brain metastases.
  • Identify multidisciplinary team members needed and patient/case characteristics that should inform treatment selection in patients with melanoma brain metastases.
  • Describe approaches for managing symptoms and quality of life issues for patients with melanoma brain metastases.
Saturday


Objectives:
  • Describe the current role of primary care physicians (PCPs) in cancer care.
  • Explain the importance of having PCPs as part of the oncology care team.
  • Identify ways to increase PCP involvement in cancer care.
Saturday
04:15pm - 05:00pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Review the specific appropriate targeted therapy for patients with metastatic non-small cell lung cancer (NSCLC) who have certain actionable oncogenic biomarkers.
  • Describe the appropriate immunotherapy regimens for patients with metastatic NSCLC who are not eligible for targeted therapies.
  • Select the optimal treatment for their patients with metastatic NSCLC.
Saturday
04:15pm - 05:00pm EDT - March 20, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Describe clinical contexts in which molecular testing may be useful for management of cutaneous melanoma.
  • Explain the challenges to using and interpreting molecular testing for diagnostic or prognostic purposes.
  • Review molecular testing options for patients with stage III or stage IV disease, what material should be used for testing, and how results may inform treatment decisions.